<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Canadian Goldcamps Corp — News on 6ix</title>
<link>https://6ix.com/company/canadian-goldcamps-corp</link>
<description>Latest news and press releases for Canadian Goldcamps Corp on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 28 Apr 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/canadian-goldcamps-corp" rel="self" type="application/rss+xml" />
<item>
<title>CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/camp4-therapeutics-preprints-pioneering-study-on-regulatory-rna-profiling-and-gene-upregulation</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/camp4-therapeutics-preprints-pioneering-study-on-regulatory-rna-profiling-and-gene-upregulation</guid>
<pubDate>Tue, 28 Apr 2026 12:00:00 GMT</pubDate>
<description>Using epigenomic mapping and regulatory RNA (regRNA) Capture-seq, CAMP4 has assembled what it bel...</description>
</item>
<item>
<title>Canadian GoldCamps Announces Extension of Price Protection for Non-Brokered Private Placement</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/canadian-goldcamps-announces-extension-of-price-protection-for-non-brokered-private-placement</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/canadian-goldcamps-announces-extension-of-price-protection-for-non-brokered-private-placement</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>Vancouver, British Columbia – TheNewswire - April 21, 2026 – Canadian GoldCamps Corp. (CSE: CAMP) (OTC: SMATF) (FSE: A68) (the “Company”) announces that, in con</description>
</item>
<item>
<title>Canadian GoldCamps Provides Corporate & Technical Work Program Updates</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/canadian-goldcamps-provides-corporate-and-technical-work-program-updates</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/canadian-goldcamps-provides-corporate-and-technical-work-program-updates</guid>
<pubDate>Tue, 14 Apr 2026 04:00:00 GMT</pubDate>
<description>Vancouver, April 14, 2026 – TheNewswire – Canadian GoldCamps Corp. (CSE: CAMP) (OTC: SMATF) (FSE: A68) is pleased to provide a corporate update following the su</description>
</item>
<item>
<title>Canadian GoldCamps Announces Definitive Option Agreement with Stelmine for Courcy & Mercator Projects</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/canadian-goldcamps-announces-definitive-option-agreement-with-stelmine-for-courcy-and-mercator-projects</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/canadian-goldcamps-announces-definitive-option-agreement-with-stelmine-for-courcy-and-mercator-projects</guid>
<pubDate>Wed, 01 Apr 2026 04:00:00 GMT</pubDate>
<description>Vancouver – TheNewswire - April 1, 2026 – Canadian GoldCamps Corp. (CSE: CAMP) (FSE: A68) (the “Company”) announces that it has entered into a definitive minera</description>
</item>
<item>
<title>CAMP4 Appoints&#xA0;Michael MacLean&#xA0;to&#xA0;its&#xA0;Board of Directors</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/camp4-appointsandxa0michael-macleanandxa0toandxa0itsandxa0board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/camp4-appointsandxa0michael-macleanandxa0toandxa0itsandxa0board-of-directors</guid>
<pubDate>Tue, 24 Mar 2026 11:00:00 GMT</pubDate>
<description>CAMBRIDGE, Mass., March 24, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation &#xA0;(&#x20...</description>
</item>
<item>
<title>CAMP4 to Participate in Upcoming Investor Conferences</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/camp4-to-participate-in-upcoming-investor-conferences-4</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/camp4-to-participate-in-upcoming-investor-conferences-4</guid>
<pubDate>Fri, 06 Mar 2026 21:05:00 GMT</pubDate>
<description>CAMBRIDGE, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (&#x201C;CA...</description>
</item>
<item>
<title>CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/camp4-reports-full-year-2025-financial-results-and-corporate-highlights-64</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/camp4-reports-full-year-2025-financial-results-and-corporate-highlights-64</guid>
<pubDate>Thu, 05 Mar 2026 21:05:00 GMT</pubDate>
<description>GLP toxicology studies ongoing for CMP-002, with initiation of global Phase 1/2 clinical trial in...</description>
</item>
<item>
<title>CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/camp4-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635c4</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/camp4-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635c4</guid>
<pubDate>Fri, 16 Jan 2026 21:05:00 GMT</pubDate>
<description>CAMBRIDGE, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation &#xA0;(&#x201...</description>
</item>
<item>
<title>Canadian GoldCamps Closes Second Tranche of Private Placement</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/canadian-goldcamps-closes-second-tranche-of-private-placement</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/canadian-goldcamps-closes-second-tranche-of-private-placement</guid>
<pubDate>Wed, 14 Jan 2026 05:00:00 GMT</pubDate>
<description>Vancouver, January 14, 2026 – TheNewswire - Canadian GoldCamps Corp. (CSE: CAMP) (FSE: A68) (the “Company”) is pleased to announce that it has closed the second</description>
</item>
<item>
<title>CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/camp4-to-present-at-the-44th-annual-jp-morgan-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/camp4-to-present-at-the-44th-annual-jp-morgan-healthcare-conference</guid>
<pubDate>Tue, 06 Jan 2026 13:00:00 GMT</pubDate>
<description>CAMBRIDGE, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation &#xA0;(&#x2...</description>
</item>
<item>
<title>Canadian GoldCamps Closes First Tranche of Private Placement and Issues LOI Consideration Shares</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/canadian-goldcamps-closes-first-tranche-of-private-placement-and-issues-loi-consideration-shares</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/canadian-goldcamps-closes-first-tranche-of-private-placement-and-issues-loi-consideration-shares</guid>
<pubDate>Fri, 02 Jan 2026 05:00:00 GMT</pubDate>
<description>Vancouver, January 2, 2026 – Canadian GoldCamps Corp. (CSE: CAMP) (FSE: A68) (the “Company”) is pleased to announce that it has closed the first tranche (the “F</description>
</item>
<item>
<title>Canadian GoldCamps Announces Management/Board Changes, Private Placement and Letter of Intent to Acquire Two Québec Gold Projects</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/canadian-goldcamps-announces-management-board-183400703</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/canadian-goldcamps-announces-management-board-183400703</guid>
<pubDate>Fri, 19 Dec 2025 18:34:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Canadian GoldCamps Corp. (CSE: CAMP) (OTC: SMATF) (FSE: A68) (the “Company”) is pleased to announce management and board changes, a non-brokered private placement financing to raise up to $1 million and a binding letter of intent (the “LOI”) in respect of a proposed option agreement to acquire two gold exploration projects in Québec from Stelmine Canada Ltd. (TSXV: STH) (“Stelmine”). MANAGEMENT AND BOARD CHANGES The Company announces</description>
</item>
<item>
<title>CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/camp4-announces-pricing-of-dollar300-million-underwritten-offering-of-common-stock</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/camp4-announces-pricing-of-dollar300-million-underwritten-offering-of-common-stock</guid>
<pubDate>Thu, 18 Dec 2025 12:10:00 GMT</pubDate>
<description>CAMBRIDGE, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (&#x201C;CAMP4...</description>
</item>
<item>
<title>CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/camp4-and-gsk-enter-strategic-collaboration-to-advance-rna-based-therapeutic-discoveries</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/camp4-and-gsk-enter-strategic-collaboration-to-advance-rna-based-therapeutic-discoveries</guid>
<pubDate>Thu, 18 Dec 2025 12:00:00 GMT</pubDate>
<description>Collaboration to leverage CAMP4&#x2019;s RAP Platform&#xAE; to accelerate development of novel an...</description>
</item>
<item>
<title>CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/camp4-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/camp4-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4</guid>
<pubDate>Fri, 12 Dec 2025 21:05:00 GMT</pubDate>
<description>CAMBRIDGE, Mass., Dec. 12, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (&#x201C;C...</description>
</item>
<item>
<title>Canadian GoldCamps Provides Update on Definitive Agreement to Acquire 70% interest in Murphy Lake Property</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/canadian-goldcamps-provides-update-on-definitive-agreement-to-acquire-70percent-interest-in-murphy-lake-property</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/canadian-goldcamps-provides-update-on-definitive-agreement-to-acquire-70percent-interest-in-murphy-lake-property</guid>
<pubDate>Fri, 05 Dec 2025 05:00:00 GMT</pubDate>
<description>Vancouver, British Columbia and Toronto, Ontario – TheNewswire - December 5, 2025 – Canadian GoldCamps Corp. (“Canadian GoldCamps”, or the “Company”) (CSE: CAMP</description>
</item>
<item>
<title>CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/camp4-reports-third-quarter-2025-financial-results-and-corporate-highlights</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/camp4-reports-third-quarter-2025-financial-results-and-corporate-highlights</guid>
<pubDate>Thu, 06 Nov 2025 21:05:00 GMT</pubDate>
<description>Strengthened balance sheet with private placement of up to $100 million to advance CMP-002, a fir...</description>
</item>
<item>
<title>CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/camp4-therapeutics-initiates-glp-toxicology-studies-for-cmp-syngap-01</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/camp4-therapeutics-initiates-glp-toxicology-studies-for-cmp-syngap-01</guid>
<pubDate>Wed, 01 Oct 2025 12:00:00 GMT</pubDate>
<description>CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (&#x20...</description>
</item>
<item>
<title>CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/camp4-announces-an-oversubscribed-private-placement-of-up-to-dollar100-million-to-advance-first-in-class-treatment-for-syngap1-related-disorders</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/camp4-announces-an-oversubscribed-private-placement-of-up-to-dollar100-million-to-advance-first-in-class-treatment-for-syngap1-related-disorders</guid>
<pubDate>Wed, 10 Sep 2025 11:00:00 GMT</pubDate>
<description>Oversubscribed Financing led by Coastlands Capital with participation from new and existing inves...</description>
</item>
<item>
<title>CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights</title>
<link>https://6ix.com/company/canadian-goldcamps-corp/news/camp4-reports-second-quarter-2025-financial-results-and-corporate-highlights</link>
<guid isPermaLink="true">https://6ix.com/company/canadian-goldcamps-corp/news/camp4-reports-second-quarter-2025-financial-results-and-corporate-highlights</guid>
<pubDate>Thu, 14 Aug 2025 20:05:00 GMT</pubDate>
<description>Presented positive translational data from SYNGAP1-related disorders program showcasing efficacy ...</description>
</item>
</channel>
</rss>